Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Asaf Oren is active.

Publication


Featured researches published by Asaf Oren.


Clinical Pediatrics | 2011

Incidence of Traumatic Lumbar Puncture: Experience of a Large, Tertiary Care Pediatric Hospital

Miguel Glatstein; Merav Zucker-Toledano; Alper Arik; Dennis Scolnik; Asaf Oren; Shimon Reif

The objective of this study was to establish the incidence of traumatic or unsuccessful lumbar punctures (LPs) in the authors’ institution. This is a prospective study. Traumatic LP was defined as >400 red blood cells (RBCs) and unsuccessful LP as failure to obtain cerebrospinal fluid (CSF) after the first LP attempt. A total of 127 CSF were recorded over 1 year. The incidence of a traumatic LP was 27/103 (26.2%) using the sitting position and 3/24 (12.5%) in infants and children using the lying position. In total, 33 (26%) CSF samples had 0 RBCs. The incidence of traumatic LP was 24% when the procedure involved one LP and 50% when more than one attempt was required. RBC count was significantly lower in cases requiring only one attempt (P = .0074). Incidence of traumatic LP was independent of physicians’ experience, sedation use or time of procedure, suggesting an intrinsic factor as the cause of traumatic LPs.


Pediatric Emergency Care | 2015

Clinical characterization of idiopathic intracranial hypertension in children presenting to the emergency department: the experience of a large tertiary care pediatric hospital.

Miguel Glatstein; Asaf Oren; Gil Amarilyio; Dennis Scolnik; Amir Ben Tov; Aiala Yahav; Arik Alper; Shimon Reif

Background Idiopathic intracranial hypertension (IIH) is a syndrome characterized by elevated intracranial pressure, without evidence of intracranial mass lesion or venous thrombosis on brain imaging. The syndrome occurs mainly in young, fertile, and overweight women but may present in any age group. The aim of this study was to report the presentation, course, and outcomes of older versus younger children presenting with IIH to the emergency department of our large tertiary care hospital during an 8-year period. Methods Retrospective chart review (January 2000-December 2008) of all patients younger than 17 years with IIH was performed on the basis of modified Dandy Criteria. The patients were analyzed according to age (<11 years and 11–17 years) and weight centile (<90%, 90%–97%, >97%). Results Ages ranged from 2 to 16.5 years (mean [SD], 9.71 [4.56] years). Thirty males (46.8%) and 33 females (53.2%) were identified: 30 were prepubertal with a male-female ratio of 1:0.56 and 33 were pubertal with a male-female ratio of 1:2 (P < 0.05). There were no significant differences between the 2 age groups in proportions of children in the 3 predefined weight categories The most common presenting symptom was headache (75%), which was significantly less common in the younger age group compared with the older group (P < 0.01). Papilledema was present in 51 patients (82.3%). Mean (SD) cerebrospinal fluid opening pressure was 378 (16) mm H2O. Findings of brain imaging (mostly computed tomographic scan), performed in all patients, were normal in 42 (67.7%); the most common finding in the remainder was swelling of the optic nerves. Conclusions Our results indicate that IIH should be considered in any child with new-onset headache or visual disturbance, irrespective of age, sex, weight, or the presence of known predisposing factors. When IIH is suspected, neuroimaging should be performed promptly to exclude secondary causes of this condition because IIH in children remains a diagnosis of exclusion. Early diagnosis and prompt treatment for IIH can prevent potential visual loss.


Hormone Research in Paediatrics | 2016

Establishing Normal Ranges of Basal and ACTH-Stimulated Serum Free Cortisol in Children.

Ori Eyal; Rona Limor; Asaf Oren; Anita Schachter-Davidov; Naftali Stern; Naomi Weintrob

Background: Normative data have been established for stimulated serum total cortisol in children but not for serum free cortisol. Methods: Children who were referred for ACTH testing to rule out adrenal insufficiency were enrolled. Only children with normal response and normal androgen levels were included. Total cortisol was determined by a chemiluminescence method, and free cortisol was measured by the same method following equilibrium dialysis. Results: The study group consisted of 85 subjects (28 male; 57 female) with a median age of 8.5 years (range 0.6-17.7). The mean basal and peak total cortisol levels were 11.5 ± 5.7 and 32.9 ± 6.2 μg/dl, respectively. The mean basal and peak free cortisol levels were 0.4 ± 0.3 and 1.8 ± 0.6 μg/dl, respectively. There was a negative correlation between peak total cortisol and age but not between peak free cortisol and age. The 3rd and 97th percentile values for peak free cortisol were 0.94 μg/dl (26 nmol/l) and 2.97 μg/dl (82 nmol/l), respectively. Conclusions: Measurement of free cortisol has the advantage of being independent of cortisol-binding globulin levels. This study provides reference ranges for stimulated free cortisol in children, with a cutoff value of 0.9 μg/dl (25 nmol/l) as a normal response to a standard ACTH test.


Endocrine Practice | 2018

SERUM FREE CORTISOL DURING GLUCAGON STIMULATION TEST IN HEALTHY SHORT-STATURED CHILDREN AND ADOLESCENTS

Naomi Weintrob; Anita Schachter Davidov; Anat Segev Becker; Galit Israeli; Asaf Oren; Ori Eyal

OBJECTIVE The total cortisol (TC) response may be measured during the glucagon stimulation test (GST) for growth hormone (GH) reserve in order to assess the integrity of the hypothalamic-pituitary-adrenal (HPA) axis. Measurements of TC are unreliable in conditions of albumin and cortisol-binding globulin (CBG) alterations (e.g., hypoproteinemia or CBG deficiency). We aimed to measure the serum free cortisol (sFC) response to the GST in children and adolescents and determine whether it could predict the GH response to glucagon stimulation. METHODS Infants and children with either short stature or growth attenuation who were referred for evaluation of GH reserve underwent the GST. RESULTS The study population consisted of 103 subjects (62 females), median age 3.9 years (range, 0.5-14). The mean basal and peak TC levels were 13.3 ± 6.7 μg/dL and 29.6 ± 8.8 μg/dL, respectively. The mean basal and peak sFC levels were 0.7 ± 0.8 μg/dL and 1.7 ± 1.1 μg/dL, respectively. There was a negative correlation between peak TC and age ( r = -0.3, P = .007) but not between peak sFC and age ( r = -0.09, P = .36). Ninety-five percent of the patients had peak TC levels >15.8 μg/dL and peak sFC levels >0.6 μg/dL. CONCLUSION Our results on a cohort of healthy short-statured children can serve as reference values for the sFC response during GST. Based on these results, we propose peak TC levels >15.8 μg/dL and peak sFC levels >0.6 μg/dL for defining normalcy of the HPA axis during the GST in children and adolescents. ABBREVIATIONS ACTH = adrenocorticotrophic hormone BMI = body mass index CBG = cortisol-binding globulin GH = growth hormone GST = glucagon stimulation test HPA = hypothalamic-pituitary-adrenal SDS = standard deviation score sFC = serum free cortisol TC = total cortisol.


Journal of Neuro-ophthalmology | 2017

Treatment Response in Pediatric Patients With Pseudotumor Cerebri Syndrome

Eliel Tovia; Shimon Reif; Asaf Oren; Alexis Mitelpunkt; Aviva Fattal-Valevski

Background: Pseudotumor cerebri syndrome (PTCS) is a disorder defined by increased intracranial pressure in the absence of an intracranial space-occupying lesion. This retrospective study aimed to examine the outcomes in children with PTCS. Methods: Data was collected retrospectively from the charts of consecutive pediatric patients treated for PTCS at our hospital between 2000 and 2007 (60 patients; 36 females, 24 males). Results: Forty-six patients (76.6%) responded well to acetazolamide therapy, with full resolution of symptoms, including papilledema (average treatment duration 1 year; range: 1 month–5 years). Of the 14 patients with no response to treatment, 9 (23.4%) required surgical intervention. Nonresponders tended to be younger at presentation (8.7 vs 11.5 years, P = 0.04). Twelve patients (26%) experienced relapse after acetazolamide was discontinued. The group that experienced relapse was significantly younger than the nonrelapsers (8.9 vs 12.1 years, P < 0.05). Conclusions: Younger age at presentation with PTCS was found to be a risk factor for treatment failure or relapse.


Hormone Research in Paediatrics | 2016

Front and Back Matter

Daniela Larizza; Catherine Klersy; Mara De Amici; Michela Albanesi; Riccardo Albertini; C. Badulli; Cristina Torre; Valeria Calcaterra; Fakhri Kallabi; Bochra Ben Rhouma; Rahma Felhi; Leila Keskes; Hassen Kamoun; Siwar Baklouti; Rania Ghorbel; Ori Eyal; Rona Limor; Asaf Oren; Anita Schachter-Davidov; Naftali Stern; Naomi Weintrob; S. Joseph; S. McCarrison; S.C. Wong; Ji Zhang; Fangqin Lin; Xiaoyi Ding; Delanie B. Macedo; Ayrton C. Moreira; Margaret Castro

Each paper needs an abstract of up to 200 words. It should be structured as follows: Background/Aims: What is the major problem that prompted the study? Methods: How was the study done? Results: Most important findings? Conclusion: Most important conclusion? Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page. Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages. Tables require a heading and figures a legend, also prepared on a separate page. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations on one block for reproduction (max. size 180  223 mm) or provide crop marks. Color illustrations Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends. Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page. References: In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as [unpublished data] and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Examples (a) Papers published in periodicals: Sun J, Koto H, Chung KF: Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 1997;112:191–195. (b) Papers published only with DOI numbers: Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858. (c) Monographs: Matthews DE, Farewell, VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996. (d) Edited books: Parren PWHI, Burton DR: Antibodies against HIV-1 from phage display libraries: Mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, 1997, vol 65, pp 18–56. Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists. Digital Object Identifier (DOI) S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org. Supplementary Material Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or


Digestive Diseases and Sciences | 2015

Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.

Doron Yablecovitch; Assaf Stein; Maytal Shabat-Simon; Timna Naftali; Gila Gabay; Ido Laish; Asaf Oren; Fred M. Konikoff


European Journal of Pediatrics | 2014

Hypoparathyroidism and central diabetes insipidus: in search of the link

Ori Eyal; Asaf Oren; Harald Jüppner; Raz Somech; Annamaria De Bellis; Michael Mannstadt; Auryan Szalat; Margalit Bleiberg; Yosef Weisman; Naomi Weintrob


Digestive Diseases and Sciences | 2017

Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease

Doron Yablecovitch; Asaf Oren; Shomron Ben-Horin; Ella Fudim; Rami Eliakim; T. Saker; Fred M. Konikoff; Uri Kopylov; T. Matthias; Aaron Lerner


Gastroenterology | 2016

Sa1399 Soluble Syndecan-1: A Potential Novel Biomarker of Small Bowel Mucosal Damage in Children With Celiac Disease

Doron Yablecovitch; Asaf Oren; Shomron Ben-Horin; Ella Fudim; Abraham R. Eliakim; Fred M. Konikoff; Uri Kopylov; Aaron Lerner

Collaboration


Dive into the Asaf Oren's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anita Schachter-Davidov

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fred M. Konikoff

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Naftali Stern

Weizmann Institute of Science

View shared research outputs
Top Co-Authors

Avatar

Rona Limor

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Shimon Reif

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Aaron Lerner

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Anat Segev-Becker

Tel Aviv Sourasky Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge